Preview of preclinical results showing a once-monthly co-formulated peptide combo that reduced weight more than an amylin-plus-GLP-1/GIP comparator in animals.
Key Takeaways
- Data demonstrate superior weight loss to the eloralintide in combination with tirzepatide in a diet-induced obese (DIO)
- ASC36_35 FDC once-monthly co-formulation is Self-Assembling Lipid Depot (SALD)
- 62 nd EASD Annual Meeting will be held in Milan, Italy, from September 28 to October 2, 2026